Authors


Joanne Mai, MPH

Latest:

New Reimbursement May Level Playing Field for Biosimilars

The new Bipartisan Budget Act of 2018 (to be in effect on January 2019) institute new reimbursement guidelines for biosimilars under the Medicare coverage gap discount program that remove disincentives for biosimilar uptake and level the playing field for the future market place.


Andrew Cournoyer, RPh, MBA

Latest:

New Reimbursement May Level Playing Field for Biosimilars

The new Bipartisan Budget Act of 2018 (to be in effect on January 2019) institute new reimbursement guidelines for biosimilars under the Medicare coverage gap discount program that remove disincentives for biosimilar uptake and level the playing field for the future market place.


Ankita Chowdhury, PhD

Latest:

New Reimbursement May Level Playing Field for Biosimilars

The new Bipartisan Budget Act of 2018 (to be in effect on January 2019) institute new reimbursement guidelines for biosimilars under the Medicare coverage gap discount program that remove disincentives for biosimilar uptake and level the playing field for the future market place.


Hoala Greevy

Latest:

4 Ways You Can Keep PHI Secure

What are the best ways for healthcare executives to keep protected health information secure? Here are some tips.


Michelle Histand

Latest:

Innovation Isn’t So Hard After All

What a movie can teach you about innovation in your organization.


David Parker, PhD

Latest:

CMS to Cover Next-Gen Sequencing for Cancer: Implications for MCOs

In a decision reached through the joint FDA/CMS Parallel Review process, CMS has granted national Medicare coverage to next-generation sequencing tests approved or cleared by the FDA as companion diagnostics for cancer therapies. This is clearly a win for Medicare beneficiaries and some NGS test providers-but is it also good news for MCOs?


Karen Richards

Latest:

CMS to Cover Next-Gen Sequencing for Cancer: Implications for MCOs

In a decision reached through the joint FDA/CMS Parallel Review process, CMS has granted national Medicare coverage to next-generation sequencing tests approved or cleared by the FDA as companion diagnostics for cancer therapies. This is clearly a win for Medicare beneficiaries and some NGS test providers-but is it also good news for MCOs?


Shelley Riser, RN, BSN, MSHA, Geneia Vice President, Consulting Services and Clinical Innovation

Latest:

Closing Care Gaps: Chart Chasing Has Become Obsolete

For far too long, chart chasing was the best method health plans had to improve HEDIS® measures and Medicare Star ratings. Now, there is a better way.


Nicolle D’Onofrio

Latest:

Top 3 Problems with Healthcare Organizations’ Content Strategies

Virtually all healthcare leaders recognize the value of content creation, yet the use of a well-defined content strategy is rare. Here’s how to get yours.


Paul Schrimpf

Latest:

Top 3 Problems with Healthcare Organizations’ Content Strategies

Virtually all healthcare leaders recognize the value of content creation, yet the use of a well-defined content strategy is rare. Here’s how to get yours.


Kevin Mehta

Latest:

A Look at the Two Sides of Bundled Payments

Why some health plans have mixed feelings on adopting bundled payments and what it can become.


John Booher

Latest:

Top 3 Opportunities for Artificial Intelligence in Healthcare

Rapid advances in the availability of big data and in machine learning offer significant opportunities to improve the healthcare system.


Jack Towsley

Latest:

Three Areas That Benefit From Provider-Led Health Plans

Starting or strengthening a provider-led health plan leads to true integration, resulting in quality care.


Steven Sullivan

Latest:

How Healthcare Organizations are Rethinking Executive Compensation

How one public trust healthcare system overhauled its overall compensation program and successfully transformed its financial operations.


Sheela Ramamurthy

Latest:

Top 3 Capabilities Health Execs Need in Care Management Technology

The right technology will enable increased population health efficiencies while simultaneously reducing the resource burden associated with managing that effort. Here are three specific capabilities to look for.



David Henka

Latest:

How Pharma Reference Pricing Can Contain Healthcare Costs

Reference pricing models are emerging as increasingly popular approaches for lowering drug costs.


Bruce A. Johnson, Janice A. Anderson, Marissa R. Urban, Neal D. Shah, and Gabriel Scott

Latest:

CMS Reevaluates Stark Law in Response to Value-Based Care Initiatives

An RFI presents an important opportunity for the healthcare industry to educate CMS on current experiences and challenges.


Wayne St. Amand

Latest:

Four Data-Driven Best Practices for Reaching Patients

Marketing analytics can help drives decision making in healthcare. Here’s four best practices healthcare marketers should live by.


Chuck Green

Latest:

Five Diabetes Factors Health Execs Should Care About

Patients with diabetes care a lot about everything from price to choice-and you should too.


Ellen Harrison

Latest:

Six Factors Holding Payers Back from Improving Star Ratings

Here’s how payers can build an action plan to directly address their Health Outcomes Survey and CAHPS Star measures, and thus impact their overall Ratings.



Meredith Williams, MD, MBA

Latest:

Five Healthcare Leadership Needs Fueled by Value-Based Care

Value-based reimbursement models require different leadership to align the practice and move it forward around a team-based model of care.


Matthew Hutt, CPA, CGMA

Latest:

How the Stark Law is an Obstacle to Care Coordination

The 30-year old regulation is in desperate need of modernization to fall in line with the changing needs of healthcare.


Jillian Godfrey Scaife

Latest:

What Health Execs Need to Know about Tissue-Agnostic Cancer Drug Trials

Basket trials are designed to test therapies that target a specific genetic mutation found in the tumor, regardless of tumor histology. This emerging trend raises a number of key questions for the industry.


John Marchisin

Latest:

Dynamic Schedule Process Benefits Hospitals, Providers, and Patients

Inaccurate forecasting of the time needed with patients can result in many negative effects, starting with a basic inability to accommodate for individual patient variability. 


Michele Meyer

Latest:

U.S. Is an Outlier When It Comes to Maternal Mortality — and Not in Good Way

The U.S. maternal mortality is 10 times higher than the rate in countries such as Australia and Japan.


Jared Safran

Latest:

Three Things Healthcare Executives Need to Know About the Retail Environment

The importance of the retail setting as a hub for health engagement is increasing. Here’s three things you need to know about it.


Emily Bridge

Latest:

Community Organization Model Tackles Veterans’ Mental Health Issues

A group of community providers around Charlotte, North Carolina, joined to create a special workgroup to ensure that veterans have the best possible support to lead healthy lives.


Allison Hart

Latest:

What Patients Want Healthcare Providers to Teach Them

Here is the one surprising thing that improves patients’ ability to effectively manage their own health.

© 2024 MJH Life Sciences

All rights reserved.